Roche

The laboratory automation project, the fifth in Egypt, reduces test result delivery time from several hours to under two, speeding up diagnosis and medical decisions.

The three-year collaboration, titled LEAD: Leadership Excellence for African Diagnostics, aims to develop a new wave of laboratory leaders equipped to strengthen health systems across the continent.

This decision follows a safety re-assessment after two non-ambulatory patients treated with Elevidys died from acute liver failure (ALF), a serious side effect linked to the therapy.

This 700,000 square-foot plant will focus on producing biologic medicines, particularly next-generation obesity drugs, for Genentech, a member of the Roche Group.

Through this MoU, Roche Diagnostics and the Sharjah Research, Technology, and Innovation Park (SRTIP) will collaborate to use biotechnology, digital health, and artificial intelligence to enable personalized medicine and improve the region’s healthcare capabilities.

The investment aims to create more than 12,000 new jobs nationwide, including nearly 6,500 construction roles and 1,000 permanent positions at new and expanded facilities.

The latest data from the OLE study, published in The Lancet, revealed that the anti-amyloid drug cut the risk of developing Alzheimer’s symptoms by 50%.